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ATR Kinase Activity Regulates the Intranuclear
Translocation of ATR and RPA
following Ionizing Radiation
both ATR and RPA translocated to small, abundant,
punctate nuclear foci, referred to hereafter as IRIF. In a
significant fraction of these IRIF, ATR and RPA were
found to colocalize, indicating that both proteins are
recruited to a similar site following DNA damage (Figures
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1E–1H). Examination of the localization of endogenous
ATR and RPA in irradiated HeLa cells yielded similar
results (see Figure S1 in the Supplemental Data availableSummary
with this article online). In addition, staining of cells ex-
pressing FATR-wt with a monoclonal antibody to theUpon damage of DNA in eukaryotic cells, several repair
FLAG epitope alone or together with a polyclonal anti-and checkpoint proteins undergo a dramatic intra-
body to ATR revealed no difference in the localizationnuclear relocalization, translocating to nuclear foci
patterns (data not shown). These results indicate thatthought to represent sites of DNA damage and repair.
the FLAG epitope does not alter the localization of ATRExamples of such proteins include the checkpoint ki-
or RPA.nase ATR (ATM and Rad3-related) as well as replica-
In undamaged cells, as expected, neither wild-typetion protein A (RPA), a single-stranded DNA binding
nor kinase-inactive FATR formed IRIF. However, weprotein required in DNA replication and repair [1, 2].
found two patterns of ATR and RPA localization prior toHere, we used a microscopy-based approach to inves-
irradiation in uninduced U2OS cells or in cells expressingtigate whether the damage-induced translocation of
FATR-wt. Consistent with previous reports [2, 6], bothRPA is an active process regulated by ATR. Our data
proteins exhibited diffuse nuclear localization in the ma-show that in undamaged cells, ATR and RPA are uni-
jority of cells. However, in30% of cells, ATR was foundformly distributed in the nucleus or localized to promy-
in a relatively small number (2–20) of large, distinct nu-elocytic leukemia protein (PML) nuclear bodies. In
clear bodies, and, in50% of cells, RPA was also foundcells treated with ionizing radiation, both ATR and RPA
in these nuclear bodies, where it colocalized with ATRtranslocate to punctate, abundant nuclear foci where
(Figures 1A–1D). Several proteins involved in the DNAthey continue to colocalize. Surprisingly, an ATR mu-
damage response have been found in promyelocytictant that lacks kinase activity fails to relocalize in
leukemia protein (PML) bodies [7]; these proteins in-response to DNA damage. Furthermore, this kinase-
clude RPA, components of the Mre11 complex, and BLMinactive mutant blocks the translocation of RPA in
[8–10]. Moreover, the protein content of PML bodies isa cell cycle-dependent manner. These observations
dynamic, and several proteins, such as Mre11, havedemonstrate that the kinase activity of ATR is essential
been found to leave PML bodies upon externally in-for the irradiation-induced release of ATR and RPA
duced stress [7, 9]. To determine if the nuclear bodiesfrom PML bodies and translocation of ATR and RPA
observed in undamaged cells were PML bodies, we cos-to potential sites of DNA damage.
tained mock- and ionizing radiation-treated U2OS cells
induced to express FATR-wt with antibodies to ATR
Results and Discussion and PML. In mock-treated cells, ATR was observed to
colocalize with PML protein (Figures 1I–1L). ATR was
To examine the role of ATR’s kinase activity in regulating also visualized in PML bodies in uninduced, undamaged
the translocation of RPA following DNA damage, we U2OS cells as well as in GM847-derived fibroblasts (data
used a pair of U2OS-derived cell lines that inducibly not shown). This indicates that ATR’s localization to
express FLAG-tagged wild-type ATR (FATR-wt) or domi- PML bodies does not result from overexpression of ATR.
nant-negative kinase-inactive ATR (FATR-ki) upon treat- However, ATR did not localize to PML bodies in HeLa
ment with doxycycline (dox). Expression of FATR-ki in cells (Figure S1). It is possible that the amount of ATR
these and other cells sensitizes them to treatment with in PML bodies varies in different cell types, or that preex-
DNA damaging agents and prevents the ionizing radia- traction of soluble protein could facilitate visualization
tion-induced G2 arrest [3–5]. Since both ATR and RPA of ATR in these bodies. Importantly, there was little colo-
have been previously reported to form ionizing radiation- calization of ATR with PML bodies in either U2OS or
induced nuclear foci (IRIF), we first sought to determine GM847 cells following ionizing radiation (Figures 1M–1P
if ATR and RPA move to the same nuclear foci following and data not shown). Consistent with our observation
treatment with ionizing radiation [1, 2]. For these experi- that RPA colocalizes with ATR in these bodies (Figure
ments, an antibody to RPA2, one component of the 1C), we also found that RPA and PML colocalized in
heterotrimeric protein, was used as a marker for RPA cells prior to but not following treatment with ionizing
localization, and ATR was identified with an affinity- radiation (data not shown). Taken together, these results
purified polyclonal antibody that recognizes both the demonstrate that ATR and RPA are found in PML bodies
endogenous and epitope-tagged protein. In cells ex- in undamaged cells and that both proteins leave these
pressing FATR-wt and treated with ionizing radiation, bodies following ionizing radiation.
To determine the role of ATR’s kinase activity in RPA
translocation, we compared the damage-induced trans-*Correspondence: cimprich@stanford.edu
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Figure 1. ATR and RPA Translocate from
PML Bodies to IRIF following Ionizing Radi-
ation
(A–H) U20S-derived cells induced to express
FATR-wt were (A–D) mock irradiated or (E–H)
treated with 50 Gy ionizing radiation, then
fixed and stained 2 hr following irradiation
with a (A and E) goat polyclonal ATR antibody
and an (B and F) RPA monoclonal antibody.
(C and G) Colocalization of ATR (green) and
RPA (red) is visualized as yellow. (D and H)
Cells were stained with Hoechst 33342 to vi-
sualize the nuclei.
(I–P) U2OS-derived cells induced to express
FATR-wt were treated as described above
and were stained with a (I and M) polyclonal
antibody to ATR and a (J and N) monoclonal
antibody to PML. (K and O) Colocalization
appears yellow. (L and P) Cells were stained
with Hoechst 33342 to visualize the nuclei.
(Q–T) U2OS-derived cells were induced to ex-
press (Q and R) FATR-wt or (S and T) FATR-
ki, exposed to ionizing radiation, and fixed 2
hr later. Cells were stained with antibodies
against ATR (green) and RPA (red) as de-
scribed in (A)–(H).
The scale bars represent 10 m.
location of both RPA and ATR in cells expressing either or DNA-PK; this finding suggests that ATM and DNA-
PK do not contribute to the ionizing radiation-inducedFATR-wt or FATR-ki (Figures 1Q–1T). Surprisingly, the
damage-induced translocation of both proteins ap- translocation of RPA under these conditions (Figures
S2B and S2C). Taken together, these results indicatepeared to occur at a lower frequency in cells that ex-
pressed FATR-ki. To determine whether the effect of that RPA is redistributed from PML bodies to IRIF follow-
ing irradiation, and that this intranuclear translocationFATR-ki on RPA localization was significant, we counted
the number of cells in which RPA was found in PML requires the kinase activity of ATR.
We then asked whether the effects of FATR-ki on thebodies or IRIF by using size, abundance, distribution,
and colocalization with PML bodies as criteria for identi- formation of RPA IRIF were dose or time dependent.
Cells uninduced (dox) or expressing FATR-ki (dox)fying RPA nuclear foci as PML bodies or IRIF. RPA local-
ized to PML bodies in 30% of mock-treated, uninduced were treated with 10 Gy, and the localization of RPA to
PML bodies or IRIF was determined at several timescells (Figure 2A), and less than 1% of these cells exhib-
ited RPA IRIF (Figure 2B). When these uninduced cells following irradiation (Figures 2C and 2D). At this lower
dose, fewer cells formed RPA IRIF and a smaller de-were treated with ionizing radiation, the localization of
RPA to PML bodies decreased to 5% (Figure 2A), while crease in the number of cells with RPA-PML bodies
was observed. We also found that the number of cellsRPA formed IRIF in 58% of these cells (Figure 2B). In
contrast, when FATR-ki was expressed, only 10% of containing RPA IRIF increased over time in the presence
or absence of FATR-ki. Importantly, however, there wasirradiated cells exhibited RPA IRIF (Figure 2B), and RPA
colocalization with PML did not significantly decrease a consistent, inhibitory effect of FATR-ki on RPA translo-
cation at each time point in irradiated cells. This indi-(Figure 2A). Similar results were obtained when cells
expressing only endogenous ATR were treated with caf- cates that the damage-induced translocation of RPA is
mediated by the kinase activity of ATR even at the lowerfeine, an inhibitor of ATR and ATM kinase activity [11]
(Figure S2A). However, there was no decrease in the dose of 10 Gy.
We then asked if ATR’s kinase activity was also re-number of cells displaying RPA IRIF in cells lacking ATM
ATR-Dependent Formation of RPA and ATR IRIF
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Figure 2. Irradiation-Induced Translocation
of RPA and ATR Requires the Kinase Activity
of ATR
(A and B) U2OS-derived FATR-ki cells ex-
pressing only endogenous ATR (dox) or in-
duced to express FATR-ki (dox) were either
mock irradiated or treated with 50 Gy ionizing
radiation, then fixed and stained with an RPA
monoclonal antibody and a polyclonal anti-
body against PML at 2 hr following irradiation.
The percentage of cells in which RPA local-
ized to (A) PML bodies or (B) IRIF or exhibited
a diffuse localization (not shown) was calcu-
lated from a minimum of 300 cells in each
of 4 independent experiments by using the
following formula: number of cells in pattern
(PML bodies or IRIF)/total number of cells. A
few cells (3%) contained both RPA IRIF and
RPA PML bodies. These cells were included
in the category of RPA PML bodies since this
appeared to be the predominant focal pat-
tern. Data are expressed as the mean stan-
dard error of four independent experiments.
(C and D) U2OS-derived FATR-ki cells ex-
pressing only endogenous ATR (dox, cir-
cles) or induced to express FATR-ki (dox,
squares) were treated with 10 Gy irradiation,
then fixed at various time points following
irradiation as indicated. Cells were stained
with antibodies against RPA and PML, and
the percentage of cells with RPA localized to
(C) PML bodies or to (D) IRIF was determined
as described in (A) and (B). A minimum of 300
cells for each condition for each of 3 indepen-
dent experiments was counted. Data are ex-
pressed as the mean standard error of three
independent experiments.
(E and F) U2OS-derived cells induced to express either FATR-wt (WT) or FATR-ki (KI) were mock treated or treated with ionizing radiation,
then fixed and stained with a monoclonal antibody to the FLAG epitope 2 hr later. At least 25 randomly selected cells for each condition (
IR, FATR-wt, or FATR-ki) from each of 3 independent experiments were imaged by using confocal microscopy. Each image was assigned
one of three groups: FATR localized to PML bodies, IRIF, or diffuse nuclear stain. The mean number of cells in each category was expressed
as a percentage of the total number of cells imaged  standard error. (E) The percentage of cells in which FATR-wt or FATR-ki localized to
PML bodies. (F) The percentage of cells in which FATR-wt or FATR-ki formed IRIF. A single, representative image of a FLAG-stained cell for
each category of FATR localization is shown.
quired for the relocalization of ATR itself. Since the anti- 1Q–1T); this finding suggests that FATR-ki also prevents
the translocation of endogenous ATR. Taken together,ATR polyclonal antibody recognizes both endogenous
and FLAG-tagged ATR, we used an anti-FLAG mono- these data demonstrate that the translocation of ATR
is more efficient when its kinase activity is intact.clonal antibody to specifically examine the ability of
FLAG-tagged ATR (wild-type and kinase-inactive) to re- Our results indicate that irradiation does not induce
the translocation of RPA or ATR in all cells and raiselocalize following DNA damage. Because ATR IRIF can
be difficult to distinguish from the diffuse nuclear back- the possibility that the damage-induced translocation
of RPA and the effects of ATR on this process mayground, each randomly selected cell was imaged by
using confocal microscopy. The criteria used to deter- be linked to the cell cycle. Therefore, we synchronized
FATR-ki cells with a double thymidine block and ana-mine whether ATR was localized to IRIF or PML bodies
were the same as described for RPA. As shown in Figure lyzed the localization of RPA in these cells at several
times following release (Figure 3A). At each time point2F, FATR-wt formed IRIF in 36% of cells, while FATR-ki
formed similar foci in only 14% of cells following ionizing in undamaged cells (/ dox), few RPA IRIF were ob-
served, while RPA localized to PML bodies in approxi-radiation. In addition, the number of cells in which FATR-
wt was found in PML bodies decreased from 26% to mately one-third of these cells. When uninduced cells
were damaged in mid-S phase (6 hr), we observed a7% following ionizing radiation (Figure 2E). In contrast,
the number of cells in which FATR-ki was found in PML significant increase in the number of cells forming RPA
IRIF and a decrease in the number of cells with RPAbodies did not significantly change following ionizing
radiation. Similar effects were observed when cells con- PML bodies. Interestingly, the number of cells forming
RPA IRIF is considerably higher than that in an asynchro-taining only endogenous ATR were treated with caffeine
(data not shown). Moreover, the same effect was seen nous population (compare 88% in Figure 3A to 58% in
Figure 2B). This number remains elevated when cellswhen cells expressing FATR-wt or FATR-ki were stained
with the anti-ATR polyclonal antibody and a monoclonal are treated with ionizing radiation in late S phase or G2
and indicates that RPA IRIF may form more readily in Santibody to RPA following ionizing radiation (Figures
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(42%). The fraction of IR-treated cells with RPA IRIF
increased only slightly as these cells progressed into
early S phase (10 hr). However, when uninduced cells
were damaged in S phase (14 hr), an elevated number
of cells (58%) formed IRIF, consistent with our findings
described in Figure 3A. These observations indicate that
the translocation of RPA is enhanced in S and G2 phase
cells. Interestingly, there was little effect of FATR-ki on
the irradiation-induced translocation of RPA in G1 phase
cells, but the effects of FATR-ki became more apparent
in S phase (14 hr). In these cells, RPA IRIF were observed
in only 28% of cells, while the fraction of cells with RPA
localized to PML bodies increased to 49% (from 15%).
Taken together, these data indicate that the transloca-
tion of RPA in S and G2 phase cells is largely ATR
dependent. Nevertheless, the irradiation-induced trans-
location of RPA that occurs in G1 cells and a portion of
S and G2 phase cells is unaffected by the expression
of ATR-ki; this finding implies that another regulatory
factor may contribute to RPA IRIF formation in a manner
that is not cell cycle specific.
In this study, we show that the intranuclear transloca-
tion of both RPA and ATR following irradiation are active
processes regulated by the kinase activity of ATR. We
find that both ATR and RPA are found in PML bodies
prior to damage, but that upon exposure of cells to
ionizing radiation, both proteins leave PML bodies and
colocalize in IRIF that may represent sites of DNA dam-
age. We have observed only limited colocalization of
ATR with phospho--H2AX (data not shown), a protein
reported to localize to double-strand breaks [12]. How-
Figure 3. RPA IRIF Formation Is Enhanced in S and G2 Phase in an ever, irradiation induces several additional types of
ATR-Dependent Manner
damage, including single-strand breaks [13] and oxida-
(A) U2OS-derived FATR-ki cells expressing only endogenous ATR
tive damage [14], some of which may activate a distinct(dox) or induced to express FATR-ki (dox) were synchronized at
checkpoint or lead to the formation of different types ofthe G1/S transition with a double thymidine block. Cells were fixed
foci. For example, oxidative damage and single-strandat various times following release, and, when indicated, cells were
irradiated with 50 Gy 2 hr prior to the fixation time noted. Cells fixed breaks could lead to replication forks stalling, which is
on coverslips were stained with antibodies against RPA and PML, thought to be a signal for ATR activation [15, 16]. A role
and, for each set of conditions, the percentage of total cells with for ATR in recognizing stalled forks is consistent with
RPA localized to PML bodies (gray bars) or IRIF (black bars) or
our observation that ATR’s effects on the translocationexhibiting a diffuse nuclear stain (not shown) was determined. Paral-
of RPA are cell cycle specific and restricted to S andlel samples were stained with propidium iodide and were analyzed
G2 phase cells.by flow cytometry to determine cell cycle status (data not shown).
The average of two independent experiments is shown. Interestingly, we have found that the formation of RPA
(B) Uninduced U2OS-derived FATR-ki cells (dox) or cells induced and ATR IRIF is accompanied by a decrease in the local-
to express FATR-ki (dox) were synchronized in mitosis by using ization of these proteins to PML bodies. Since all cells
nocodazole. Cells were treated and data were obtained as described
do not form the ATR/RPA PML bodies or IRIF, and sincein (A).
the number of cells forming RPA IRIF is sometimes
greater than the number of cells with RPA PML bodies
and G2 phase cells. In contrast, expression of FATR-ki (for example, compare Figures 2A and 2B), some of the
in irradiated cells reduced the formation of RPA IRIF RPA must translocate from the nucleoplasm to IRIF.
and inhibited translocation of RPA out of PML bodies This could indicate that the translocation out of PML
in S and G2 phase cells. These results suggest that the bodies and to IRIF may be independent processes that
kinase activity of ATR is needed for efficient relocaliza- occur in different cells. However, it is striking that the
tion of RPA in S and G2 phase cells. kinase activity of ATR is required for both events, and
To further examine the effects of the cell cycle on this requirement links these two translocation events
RPA translocation, we analyzed RPA localization in cells and suggests that they may occur in the same cell. PML
released from a nocodazole block at various times in bodies contain both stable and dynamic components
G1 and early S phase (Figure 3B). In undamaged cells [17], and it has been suggested that certain proteins
(/ dox) synchronized in G1 or S phase, RPA localized pass transiently through PML bodies where they are
to PML bodies in 40%–50% of cells and no IRIF were modified and/or form protein complexes [18]. Alterna-
observed. In uninduced, irradiated cells fixed at 6 hr, tively, PML bodies may serve to sequester certain
RPA IRIF were visualized in only 22% of cells, while the checkpoint and repair proteins until their function is
needed. In this context, it is interesting that Chk2, whichnumber of cells with RPA in PML bodies remained high
ATR-Dependent Formation of RPA and ATR IRIF
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damaging agents and defects in cell cycle checkpoints. EMBOis regulated by ATM [19], phosphorylates the PML pro-
J. 17, 159–169.tein after ionizing radiation and disrupts an interaction
6. Zou, L., Cortez, D., and Elledge, S.J. (2002). Regulation of ATRbetween PML and Chk2 that exists before damage [20].
substrate selection by Rad17-dependent loading of Rad9 com-
How might ATR regulate the localization of RPA? We plexes onto chromatin. Genes Dev. 16, 198–208.
have found that RPA is a substrate for ATR both in vitro 7. Negorev, D., and Maul, G.G. (2001). Cellular proteins localized at
and interacting within ND10/PML nuclear bodies/PODs suggestand in vivo (Figure S3), raising the possibility that ATR
functions of a nuclear depot. Oncogene 20, 7234–7242.mediates the translocation of RPA through direct phos-
8. Lombard, D.B., and Guarente, L. (2000). Nijmegen breakagephorylation. However, we have also found that mutation
syndrome disease protein and MRE11 at PML nuclear bodiesof two consensus ATR phosphorylation sites in RPA
and meiotic telomeres. Cancer Res. 60, 2331–2334.
does not affect the ability of RPA to form IRIF (unpub- 9. Mirzoeva, O.K., and Petrini, J.H. (2001). DNA damage-depen-
lished data). Although it is still possible that phosphory- dent nuclear dynamics of the Mre11 complex. Mol. Cell. Biol.
21, 281–288.lation of an unidentified ATR-specific site in RPA is in-
10. Bischof, O., Kim, S.H., Irving, J., Beresten, S., Ellis, N.A., andvolved, it seems more likely that ATR’s effects on RPA
Campisi, J. (2001). Regulation and localization of the Bloomlocalization may be indirect.
syndrome protein in response to DNA damage. J. Cell Biol. 153,In summary, we have shown that the kinase activity
367–380.
of ATR plays a critical function in regulating the damage- 11. Sarkaria, J.N., Busby, E.C., Tibbetts, R.S., Roos, P., Taya, Y.,
induced intranuclear translocation of both RPA and ATR, Karnitz, L.M., and Abraham, R.T. (1999). Inhibition of ATM and
ATR kinase activities by the radiosensitizing agent, caffeine.indicating that these are active, regulated processes. In
Cancer Res. 59, 4375–4382.addition, we have shown that ATR is found in PML bod-
12. Paull, T.T., Rogakou, E.P., Yamazaki, V., Kirchgessner, C.U.,ies before DNA damage and that its kinase activity af-
Gellert, M., and Bonner, W.M. (2000). A critical role for histonefects its own localization to these bodies as well as that
H2AX in recruitment of repair factors to nuclear foci after DNA
of RPA. These results shed new insights into the function damage. Curr. Biol. 10, 886–895.
of PML nuclear structures and the mechanisms control- 13. Ward, J.F. (1988). DNA damage produced by ionizing radiation
in mammalian cells: identities, mechanisms of formation, andling the dynamic movement of checkpoint and repair
repairability. Prog. Nucleic Acid Res. Mol. Biol. 35, 95–125.proteins following DNA damage.
14. Sutherland, B.M., Bennett, P.V., Sutherland, J.C., and Laval, J.
(2002). Clustered DNA damages induced by x rays in humanSupplemental Data
cells. Radiat. Res. 157, 611–616.Supplemental Data including Figures S1–S3 and a more detailed
15. Lupardus, P.J., Byun, T., Yee, M.C., Hekmat-Nejad, M., anddescription of the Experimental Procedures used in this study are
Cimprich, K.A. (2002). A requirement for replication in activationavailable at http://www.current-biology.com/content/supplemental.
of the ATR-dependent DNA damage checkpoint. Genes Dev.
16, 2327–2332.
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